I had another listen to last week’s presentation. Jon seemed...

I had another listen to last week’s presentation. Jon seemed very neutral in hindsight. He started with the results (Angelman) will give us ‘and others’ confidence and finished by acknowledging that we have been in talks with numerous pharmaceutical companies but no further details are to be given until after the FDA meeting.

Another question I missed was, if we had been given an unsolicited take out offer which he said he obviously couldn’t comment on.

Given everything we have achieved it’s very tough being back at this share price. The next 4 months are going to be very interesting though. I can’t help but think the continual Reeta reference is of importance. Time will tell, hopefully we are at the pointy end, it’s been a long journey.